Page last updated: 2024-10-24

negative regulation of macrophage differentiation

Definition

Target type: biologicalprocess

Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage differentiation. [GOC:go_curators]

Negative regulation of macrophage differentiation is a complex process that involves a variety of signaling pathways and transcription factors. It is essential for maintaining tissue homeostasis and preventing excessive inflammation. Here's a breakdown of the key steps involved:

**1. Inhibition of Macrophage Colony-Stimulating Factor (M-CSF) Signaling:**
- M-CSF is a critical cytokine that promotes the differentiation of monocytes into macrophages.
- Negative regulation can occur by:
- Blocking M-CSF production by cells like fibroblasts and endothelial cells.
- Inhibiting M-CSF receptor (CSF1R) expression on monocytes.
- Interfering with M-CSF binding to CSF1R.
- Downregulating downstream signaling pathways activated by CSF1R, such as the RAS-RAF-MEK-ERK pathway.

**2. Suppression of Transcription Factors Involved in Macrophage Differentiation:**
- Several transcription factors, like PU.1, C/EBPα, and IRF8, play key roles in macrophage differentiation.
- Negative regulation can occur by:
- Inhibiting their expression through epigenetic modifications (e.g., DNA methylation) or by microRNAs.
- Blocking their binding to target genes involved in macrophage differentiation.

**3. Induction of Inhibitory Transcription Factors:**
- Some transcription factors, such as GATA-2 and STAT6, can suppress macrophage differentiation.
- Their expression can be upregulated by signaling pathways like IL-4 signaling, which promotes alternative activation of macrophages (M2 macrophages) that typically suppress inflammation.

**4. Activation of Anti-inflammatory Signaling Pathways:**
- Pathways like the IL-10 signaling pathway can inhibit macrophage differentiation and promote an anti-inflammatory state.
- IL-10 can suppress the expression of pro-inflammatory cytokines and induce the production of anti-inflammatory factors.

**5. Inhibition of Cell Cycle Progression:**
- Macrophage differentiation often involves cell cycle progression.
- Negative regulation can involve:
- Inducing cell cycle arrest in monocytes.
- Downregulating expression of proteins involved in cell cycle control, such as cyclins and CDKs.

**6. Induction of Apoptosis:**
- In some cases, negative regulation of macrophage differentiation can involve inducing programmed cell death (apoptosis) in monocytes, preventing their differentiation into macrophages.

**Factors influencing negative regulation:**
- The specific microenvironment and the presence of various signaling molecules can influence the extent of negative regulation of macrophage differentiation.
- For example, tissue-specific factors or immune responses can modulate the balance between macrophage differentiation and suppression.

In summary, negative regulation of macrophage differentiation is a complex process that involves multiple levels of control. It plays a critical role in maintaining tissue homeostasis, preventing excessive inflammation, and ensuring proper immune function.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Tyrosine-protein phosphatase non-receptor type 2A tyrosine-protein phosphatase non-receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17706]Homo sapiens (human)
Inhibin alpha chainAn inhibin alpha chain that is encoded in the genome of human. [PRO:CNA, UniProtKB:P05111]Homo sapiens (human)

Compounds (31)

CompoundDefinitionClassesRoles
5-iodo-2-(oxaloamino)benzoic acidorganoiodine compound
lithocholic acidlithocholate : A bile acid anion that is the conjugate base of lithocholic acid.

lithocholic acid : A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action.

Lithocholic Acid: A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.
bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid
geroprotector;
human metabolite;
mouse metabolite
glycyrrhetinic acidcyclic terpene ketone;
hydroxy monocarboxylic acid;
pentacyclic triterpenoid
immunomodulator;
plant metabolite
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
vanadatesvanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms.

Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects.
trivalent inorganic anion;
vanadium oxoanion
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
madecassic acidmonocarboxylic acid;
pentacyclic triterpenoid;
tetrol
antioxidant;
plant metabolite
maslinic acid(2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoriadihydroxy monocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
geniposideterpene glycoside
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
cryptotanshinonecryptotanshinone: from Salvia miltiorrhizaabietane diterpenoidanticoronaviral agent
boswellic acidboswellic acid: ursane type; RN given refers to (3alpha,4beta)-isomer; active principle of salai guggal; see also record for salai guggaltriterpenoid
procurcumenolprocurcumenol: RN given for (1S-(1alpha,3abeta,8aalpha))-isomer; epiprocurcumenol is the (1S-(1alpha,3aalpha,8aalpha))-isomer; a TNF-alpha antagonist isolated from Curcuma zedoaria; structure in first sourcesesquiterpenoid
pinocembrin
genipiniridoid monoterpenoidanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cross-linking reagent;
hepatotoxic agent;
uncoupling protein inhibitor
2-(oxaloamino)benzoic acid(oxaloamino)benzoic acid
chlorogenic acidcaffeoylquinic acid: Antiviral Agent; structure in first source

chlorogenate : A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3.
cinnamate ester;
tannin
food component;
plant metabolite
tocopherylquinonetocopherylquinone: RN refers to (3R-(3R*,7R*,11R*))-isomer; structure
illudalic acidilludalic acid: isolated from Clitocybe illudens; structure in first source
eupatoriopicrinegermacranolide
cannabigerolcannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species.

cannabigerol: RN given refers to (E)-isomer; structure given in first source
phytocannabinoid;
resorcinols
anti-inflammatory agent;
antibacterial agent;
antioxidant;
appetite enhancer;
cannabinoid receptor agonist;
neuroprotective agent;
plant metabolite
2-amino-6-chloropurine6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6.

6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source
2-aminopurines;
organochlorine compound
corosolic acidtriterpenoidmetabolite
11-keto-boswellic acid
3-epioleanolic acidtriterpenoidmetabolite
oleanonic acidoleanonic acid: structure in first source
zedoarondiolzedoarondiol: structure in first source
formylchromoneformylchromone: structure in first source
rk 682
variabilinvariabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source